Healthcare Services

Global Metagenomic Sequencing Market Expected to Reach $5.13 Billion by 2030 with 15.1% CAGR

April 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Metagenomic Sequencing Market At The End Of The 2026–2030 Forecast Period?

The metagenomic sequencing market size has experienced swift expansion in recent years. It is anticipated to increase from $2.5 billion in 2025 to $2.92 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 17.1%. This historical growth can be linked to the increasing use of NGS, the early adoption of microbial community studies, a rising demand for DNA extraction kits, growth in environmental microbiology research, and the expansion of clinical diagnostics.

The metagenomic sequencing market is set for rapid expansion in the coming years. Its valuation is projected to reach $5.14 billion by 2030, expanding at a compound annual growth rate (CAGR) of 15.1%. This anticipated growth is fueled by advancements in sequencing technologies, the rise of microbiome-based therapeutics, increasing investment in bioinformatics, a growing demand for cloud-based genomic analysis, and the wider adoption of precision medicine applications. Major trends expected during this period include the expansion of precision genomics through high-throughput sequencing, AI-driven metagenomic data analysis, the automation of sample preparation and sequencing workflows, cloud-based bioinformatics platforms for managing large datasets, and IoT-enabled environmental microbiome monitoring.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16117&type=smp

What Primary Drivers Are Shaping The Development Of The Metagenomic Sequencing Market?

The increasing incidence of tuberculosis (TB) is anticipated to drive the expansion of the metagenomic sequencing market in the coming years. Tuberculosis is a highly contagious infectious illness caused by Mycobacterium tuberculosis, primarily targeting the lungs and spreading through airborne droplets when infected individuals cough or sneeze. The rise in TB cases is attributed to factors such as global migration, compromised immune systems, antimicrobial resistance, and deficiencies in public health surveillance. Metagenomic sequencing aids TB detection by offering rapid, unbiased identification of pathogens, pinpointing drug-resistance genes, and improving the tracking of outbreaks, all of which are crucial for managing evolving infectious threats. For instance, in March 2024, data from the Centers for Disease Control and Prevention, a US-based government agency, indicated that the count of tuberculosis cases grew from 8,320 in 2022 to 9,615 in 2023, marking a rise of 1,295 cases. Therefore, the escalating challenge of tuberculosis is a significant driver for the metagenomic sequencing market’s growth.

What Segment Types Make Up The Metagenomic Sequencing Market?

The metagenomic sequencing market covered in this report is segmented –

1) By Product And Service: Reagents And Consumables, Instruments, Sequencing Services, Analysis And Data Interpretation Solutions

2) By Technology: 16S RNA Sequencing, Shotgun Metagenomic Sequencing, Whole-Genome Sequencing And De Novo Assembly, Metatranscriptomics

3) By Application: Clinical Diagnostic, Environmental Remediation, Gut Microbe Characterization, Drug Discovery, Biofuel, Agriculture, Other Applications

Subsegments:

1) By Reagents And Consumables: DNA Or RNA Extraction Kits, Library Preparation Kits, Sequencing Kits, PCR And qPCR Reagents, Other Consumables (Buffers, Probes)

2) By Instruments: Next-Generation Sequencers (NGS), Third-Party Sequencers, Microarrays, Real-Time PCR Instruments

3) By Sequencing Services: Whole Genome Sequencing (WGS), 16S rRNA Sequencing, Shotgun Metagenomic Sequencing, Amplicon Sequencing, Metatranscriptomic Sequencing

4) By Analysis And Data Interpretation Solutions: Bioinformatics Software, Cloud-Based Data Analysis Services, Data Storage Solutions, Custom Analysis Tools, Data Interpretation Platforms

What Major Market Trends Are Driving Changes In The Metagenomic Sequencing Market?

Key players in the metagenomic sequencing market are concentrating on innovating sequencing services to enhance accuracy, throughput, and cost-effectiveness. These sequencing services represent advanced genomic technologies that facilitate the sequencing of longer DNA fragments, thereby offering a more thorough understanding of genetic structures compared to traditional short-read techniques. For instance, in April 2024, Clinical Microbiomics A/S, a Denmark-based biotechnology company, rolled out advanced long-read sequencing services, encompassing 16S, ITS, 18S rRNA, custom gene sequencing, and comprehensive genomics and metagenomics. These services provide unmatched resolution and quality in microbial analysis, enabling detailed insights into microbial communities and aiding in the creation of high-quality metagenome-assembled genomes.

Who Are The Key Players Driving Competition In The Metagenomic Sequencing Market?

Major companies operating in the metagenomic sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Merck Co. & KGaA, Eurofins Scientific SE, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Beijing Genomics Institute Group, Azenta Inc., Promega Corporation, Novogene Co. Ltd., Oxford Nanopore Technologies plc, Zymo Research Corporation, Metagenomi Inc., Psamogen Inc., IntegraGen SA, Karius Inc., DNAStar Inc., Macrogen Inc., Takara Bio Inc., Arc Bio LLC, Microsynth AG, Computomics GmbH, COSMOSID Inc., Phase Genomics Inc., Era7 Bioinformatics GmbH

Read the full metagenomic sequencing market report here:

https://www.thebusinessresearchcompany.com/report/metagenomic-sequencing-global-market-report

How Does The Metagenomic Sequencing Market Perform Across Major Global Regions?

North America was the largest region in the metagenomic sequencing market in 2025. Asia-Pacific is expected to be the fastest growing region in the market. The regions covered in the metagenomic sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Metagenomic Sequencing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16117&type=smp

Browse Through More Reports Similar to the Global Metagenomic Sequencing Market 2026, By The Business Research Company

Pharmacies And Healthcare Stores Global Market Report

https://www.thebusinessresearchcompany.com/report/pharmacies-and-healthcare-stores-global-market-report

Digital Health Global Market Report

https://www.thebusinessresearchcompany.com/report/digital-health-global-market-report

Telehealth Global Market Report

https://www.thebusinessresearchcompany.com/report/telehealth-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795